U.S. market Open. Closes in 3 hours 19 minutes

ESPR | Esperion Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312002-12-312001-12-312000-12-311999-12-31
Revenue116.33M75.47M78.45M227.55M148.36M184.47MN/AN/AN/AN/AN/AN/AN/AN/AN/A2.00KN/A
Cost of Revenue43.43M26.97M14.22M2.39M175.61MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A786.00K683.22K
Gross Profit72.90M48.51M64.23M225.16M-27.25M184.47MN/AN/AN/AN/AN/AN/AN/AN/AN/A-784.00K-683.22K
Operating Expenses228.47M228.01M290.96M346.55M241.47M204.59M168.98M76.15M50.04M36.22M22.76MN/AN/AN/AN/A26.79M11.69M
Selling, General & Admin142.36M109.08M184.99M199.62M65.85M33.10M21.38M18.28M20.24M10.92M6.74M2.21M2.36MN/AN/AN/AN/A
Research & Development86.11M118.93M105.97M146.94M175.61M171.49M147.60M57.87M29.80M25.30M16.01M8.00M7.81M21.99M21.45M21.79M8.48M
Other Operating Expenses5.29M2.65M3.98M515.00K4.06M2.77MN/AN/AN/AN/AN/AN/AN/AN/AN/A5.00M3.20M
Operating Income-155.56M-179.50M-226.73M-121.40M-93.10M-204.59M-168.98M-76.15M-50.04M-36.22M-22.76M-10.20M-10.16M-29.24M-29.33M-27.57M-12.37M
Other Expenses / Income-53.69M-54.16M-42.38M-22.16M-4.06M2.77M1.99M1.17M256.00K-151.00K-3.33M-1.54M-652.97K511.00K4.40M-3.80MN/A
Before Tax Income-209.25M-233.66M-269.11M-143.55M-97.17M-201.81M-166.99M-74.98M-49.78M-36.38M-26.09M-11.74M-10.82M-28.73M-24.93MN/AN/A
Income Tax Expenses-3.90K54.16M49.72M22.64M11.86M2.88MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-209.25M-287.82M-318.82M-166.19M-109.02M-201.81M-166.99M-74.98M-49.78M-36.38M-26.09M-11.74M-10.82M-28.73M-24.93M-27.58M-10.67M
Interest Expenses58.98M56.81M46.35M22.67M8.12M100.00K198.00K376.00K520.00K270.00K936.58K1.49M577.16KN/AN/AN/AN/A
Basic Shares Outstanding103.11M66.41M28.90M27.47M27.09M26.75M23.93M22.54M22.02M16.37M7.89M537.54K722.50K4.19M3.91M2.95M1.34M
Diluted Shares Outstanding103.11M66.41M28.90M27.47M27.09M26.75M23.93M22.54M22.02M16.37M7.89M537.54K722.50K4.19M3.91M2.95M1.34M
EBITDA-155.40M-176.85M-222.75M-120.88M-89.05M-204.59M-166.53M-75.90M-49.80M-36.06M-22.69M-10.15M-10.06M-27.21M-26.80M-29.63M-11.69M
EBITDA Margin-133.58%-234.31%-283.96%-53.12%-60.02%-110.90%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,481,300.00%0.00%
EBIT-150.28M-176.85M-222.75M-120.88M-89.05M-198.84M-166.79M-74.60M-49.26M-36.10M-25.15M-10.26M-10.24M-28.73M-24.93M-27.58M-10.67M
EBIT Margin-129.18%-234.31%-283.96%-53.12%-60.02%-107.78%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,378,800.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙